| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1566 | 2010 |
| Update of EULAR recommendations for the treatment of systemic sclerosis O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ... Annals of the rheumatic diseases 76 (8), 1327-1339, 2017 | 1169 | 2017 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 579 | 2017 |
| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 506 | 2020 |
| Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase … R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots, Z Luo, R DeMasi, ... The Lancet 390 (10093), 457-468, 2017 | 490 | 2017 |
| Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group S Jordan, JHW Distler, B Maurer, D Huscher, JM Van Laar, Y Allanore, ... Annals of the rheumatic diseases 74 (6), 1188-1194, 2015 | 490 | 2015 |
| Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis Y Allanore, C Meune, MC Vonk, P Airo, E Hachulla, P Caramaschi, ... Annals of the rheumatic diseases 69 (01), 218-221, 2010 | 313 | 2010 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 234 | 2017 |
| “To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity S Cappelli, SB Randone, D Martinović, MM Tamas, K Pasalić, Y Allanore, ... Seminars in arthritis and rheumatism 41 (4), 589-598, 2012 | 209 | 2012 |
| Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study M Elhai, M Boubaya, O Distler, V Smith, M Matucci-Cerinic, JJA Sancho, ... Annals of the rheumatic diseases 78 (7), 979-987, 2019 | 196 | 2019 |
| Digital ulcers predict a worse disease course in patients with systemic sclerosis C Mihai, R Landewé, D Van Der Heijde, UA Walker, PI Constantin, ... Annals of the rheumatic diseases 75 (4), 681-686, 2016 | 184 | 2016 |
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study M Elhai, J Avouac, UA Walker, M Matucci-Cerinic, G Riemekasten, P Airò, ... Annals of the rheumatic diseases 75 (1), 163-169, 2016 | 144 | 2016 |
| An update on the effects of vitamin D on the immune system and autoimmune diseases C Sîrbe, S Rednic, A Grama, TL Pop International journal of molecular sciences 23 (17), 9784, 2022 | 138 | 2022 |
| The contribution of ultrasonography and sonoelastography in assessment of myositis C Botar-Jid, L Damian, SM Dudea, D Vasilescu, S Rednic, R Badea Medical Ultrasonography 12 (2), 120-126, 2010 | 134 | 2010 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 118 | 2021 |
| Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 104 | 2019 |
| Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database EG Wirz, VK Jaeger, Y Allanore, G Riemekasten, E Hachulla, O Distler, ... Annals of the rheumatic diseases 75 (7), 1285-1292, 2016 | 102 | 2016 |
| Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis R Cosgarea, R Tristiu, RB Dumitru, NB Arweiler, S Rednic, CI Sirbu, ... Clinical oral investigations 23, 141-151, 2019 | 91 | 2019 |
| Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group VK Jaeger, O Distler, B Maurer, L Czirják, V Lóránd, G Valentini, S Vettori, ... Rheumatology 57 (3), 441-450, 2018 | 88 | 2018 |
| EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres C Pamfil, A Fanouriakis, L Damian, M Rinzis, P Sidiropoulos, G Tsivgoulis, ... Rheumatology 54 (7), 1270-1278, 2015 | 74 | 2015 |
Cristina PamfilAssistant Professor of Rheumatology, Iuliu Hatieganu University of Medicine and Pharmacy, ClujDirección de correo verificada de umfcluj.ro
